Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Status:
Terminated
Trial end date:
2011-01-18
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. It is not yet known whether gemcitabine is more effective when given
together with or without capecitabine in treating patients with biliary cancer.
PURPOSE: This randomized phase III trial is studying giving gemcitabine together with
capecitabine to see how well it works compared with giving gemcitabine alone in treating
patients with locally advanced, unresectable, or metastatic biliary cancer.